Ottobock SE & Co. KGaA (ETR:OBCK)
Germany · Delayed Price · Currency is EUR 46.42
-5.03 (-9.78%)
At close: Mar 20, 2026
Ottobock SE & Co. KGaA Revenue
In the year 2025, Ottobock SE & Co. KGaA had annual revenue of 1.68B EUR with 4.69% growth. Ottobock SE & Co. KGaA had revenue of 462.00M in the quarter ending December 31, 2025, with 4.98% growth.
Revenue
1.68B
Revenue Growth
+4.69%
P/S Ratio
1.77
Revenue / Employee
181.48K
Employees
9,256
Market Cap
2.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.68B | 75.20M | 4.69% |
| Dec 31, 2024 | 1.60B | 109.56M | 7.33% |
| Dec 31, 2023 | 1.50B | 160.84M | 12.06% |
| Dec 31, 2022 | 1.33B | 146.69M | 12.35% |
| Dec 31, 2021 | 1.19B | 734.58M | 162.18% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bayer Aktiengesellschaft | 45.58B |
| Siemens Healthineers AG | 23.30B |
| Fresenius SE & Co. KGaA | 22.45B |
| Merck KGaA | 21.10B |
| Fresenius Medical Care AG | 19.63B |
| Redcare Pharmacy NV | 2.94B |
| Fielmann Group AG | 2.42B |
| Carl Zeiss Meditec AG | 2.20B |